Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFazeelat Bibi

About this trial

This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.

Eligibility criteria

Qualifiers

Adults > 18 years diagnosed with chronic wounds (duration > 6 weeks)

Wound size between 5 and 10 cm²

Ankle-Brachial Pressure Index (ABPI) > 0.8 for venous leg ulcers

Palpable pulses for diabetic foot ulcers

Disqualifiers

Patients receiving immunosuppressive therapy or corticosteroids

Presence of malignancy

Patients who do not provide informed consent

Trial design

Treatments tested in this trial

  • Topical Tetrachlorodecaoxide (TCDO/Oxoferin)
  • Standard Wound Care

Treatment groups

66 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fazeelat Bibi

Lead sponsor

Khyber Teaching Hospital

Sponsor institution